A recovery model of minimally invasive cardiopulmonary bypass in the rat

Modine, T.; Azzaoui, R.; Fayad, G.; Lacroix, D.; Bordet, R.; Warembourg, H.; Gourlay, T.
March 2006
Perfusion;Mar2006, Vol. 21 Issue 2, p87
Academic Journal
This study was undertaken to develop a rodent (rat) model of cardiopulmonary bypass (CPB) that has been designed to mimic functionally the minimally invasive clinical setting. The circuit is similar to the clinical model in terms of its construction, configuration, material surface area to blood volume ratio, and priming volume to blood ratio. The overall priming volume was 10 mL. Thirty-six male Sprague-Dawley rats (422±32 g) were anaesthetized while maintaining spontaneous ventilation. Anticoagulation was achieved with heparin (500 IU/kg). Blood arterial pressure was monitored continuously. Normal central temperature was maintained throughout. Intermittent arterial blood gas levels also were monitored. All animals were cannulated in preparation for CPB; however, CPB, utilizing a double roller pump and a flow rate of 100 mL/kg/minute for 60 min, was initiated in only 18 animals, the remaining 18 animals acting as non-CPB controls (Sham). The animals were haemodynamically stable. After the operative procedure, the animals were allowed to recover from the anaesthesia and, after transfer to a recovery facility, were monitored for a period of 1 week. There were no differences between the groups in terms of blood gas analysis and blood pressure data; all animals survived the procedure and had an uneventful follow-up. Differences were found between the CPB animals and the Sham group in terms of TNFα, used as a marker of inflammatory processes. This trend tends to support this model as an analogue for the clinical scenario for future studies of CPB-related inflammation. Overall, the CPB procedure was easy to perform and was associated with excellent survival. This recovery model is an effective tool to perform pathophysiological studies associated with minimally invasive CPB.


Related Articles

  • CPB in high-risk groups: CPB in diabetics. Birnbaum, Dietrich E.; Lehle, Karla // Perfusion;Jul2006, Vol. 21 Issue 4, p235 

    The article discusses about cardiopulmonary bypass (CPB) in diabetic patients. Sufficient blood pressure for renal circulation needs to be maintained consistently throughout the CPB procedure. Each patient's circulation during management of anesthesia and CPB, needs to be regulated. It is...

  • Reply from the authors. Boly, C. A.; Bouwman, R. A.; Reesink, K. D. // BJA: The British Journal of Anaesthesia;Mar2014, Vol. 112 Issue 3, p579 

    No abstract available.

  • Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass. Gruenwald, C.; de Souza, V.; Chan, A.; Andrew, M. // Perfusion;Jun2000, Vol. 15 Issue 3, p203 

    This study was designed to test the validity of whole blood heparin concentration (WHBC) measurements using an on-site protamine titration assay with the Hepcon instrument (Medtronic Blood Management, Parker, CO, USA) in pediatric patients less than 1 year old undergoing cardiopulmonary bypass...

  • Editorial. Kurusz, M. // Perfusion;May2008, Vol. 23 Issue 3, p145 

    The article discusses various reports published within the issue, including one by Puri and colleagues on a new monitoring tool for cerebral venous congestion during cardiopulmonary bypass and another by Kordis and colleagues on the benefit of a heparin-coated minimized extracorporeal circuit.

  • Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction. Flom-Halvorsen, Hanne I; Øvrum, E; Brosstad, F; Tangen, G; Ringdal, MAL; Øystese, R // Perfusion;Sep2002, Vol. 17 Issue 5, p339 

    Objective: The two most commonly used heparin-coated systems for cardiopulmonary bypass (CPB) are the Carmeda Bio-Active Surface (CBAS) (Medtronic, Minneapolis, MN, USA) and the Duraflo II coating (Baxter Healthcare, Irvine, CA, USA). The two surfaces are technically unequal and previous...

  • Cerebral Oximetry Monitoring During Preoperative Phlebotomy to Limit Allogeneic Blood Use in Patients Undergoing Cardiac Surgery. Dewhirst, Elisabeth; Winch, Peter; Naguib, Aymen; Galantowicz, Mark; Tobias, Joseph // Pediatric Cardiology;Jan2013, Vol. 34 Issue 1, p75 

    Preoperative phlebotomy can minimize the need for allogenic blood products. Frequently, removed blood is replaced with intravenous fluids to maintain euvolemia (acute normovolemic hemodilution [ANH]). During cardiopulmonary bypass (CPB), ANH may present problems when the circuit prime causes...

  • Influence of the timing of administration of crystalloid on maternal hypotension during spinal anesthesia for cesarean delivery: preload versus coload. Ah-Young Oh; Jung-Won Hwang; In-Ae Song; Mi-Hyun Kim; Jung-Hee Ryu; Park, Hee-Pyoung; Yeong-Tae Jeon; Sang-Hwan Do // BMC Anesthesiology;2014, Vol. 14 Issue 1, p1 

    Background Prophylactic fluid preloading before spinal anesthesia has been a routine procedure to prevent maternal hypotension during cesarean delivery. Unlike colloid, timing of infusion of crystalloid may be important because of its short stay in intravascular space. We hypothesized that...

  • Anesthetic management of heterotopic heart transplantation on beating heart. Kılıckan, Levent; Baykara, Nur; Toker, Kamil; Tekinalp, Haldun; Akbasş, Haluk; Alp, Mete // Journal of Anesthesia;2000, Vol. 14 Issue 2, p109 

    Presents a method of anesthesia and a technique for heterotopic heart transplantation without cardiopulmonary bypass. Details of the case of a man who had end-stage dilated cardiomyopathy; Indications for heterotopic heart transplantation; Why heterotopic heart transplantation has been...

  • Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography. Iqbal, A.; Morton, C.; Kong, K.-L. // BJA: The British Journal of Anaesthesia;Aug2010, Vol. 105 Issue 2, p168 

    A large and ever-growing number of agents used in anaesthesia can precipitate acute anaphylactic reactions after their administration. Anaphylaxis is a sudden onset (or rapidly progressive), severe systemic allergic reaction, affecting multiple organ systems. The number of people who suffer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics